In a small German port city on the North Sea coast, the 15 men and women who make up GAG Bioscience are gearing up to take on the industry leader in scrapie-susceptibility genotyping.

The tiny company, based in Bremen, hopes its mass spectrometry-based genotyping technology will catch up to Orchid Biosciences’ technology as the preeminent platform for eradicating scrapie from the world’s sheep population, and will help animal-health officials breed resistant sheep.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.